PETS Cuplikan Saham Harga, kapitalisasi pasar, P/E, EPS, ROE, utang/ekuitas, kisaran 52 minggu

03
Harga $1.36
Kapitalisasi Pasar (MRQ) $29M
P/E (TTM) -1.0
EPS (TTM) $-1.37
Pendapatan (TTM) $169M
Imbal Hasil Dividen 0.07%
ROE (TTM) -78.6%
Rentang 52M $1–$4

PETS Grafik Harga Saham OHLCV harian dengan indikator teknis — geser, perbesar, dan sesuaikan tampilan Anda

04
rentang
batang

Granularitas batang menyesuaikan dengan periode yang dipilih — arahkan kursor ke bagan untuk melihat buka/tinggi/rendah/tutup untuk sebuah batang.

Tentang PetMed Express, Inc. - Common Stock Tinjauan perusahaan dari Wikipedia

05 · wikidata

PetMed Express, Inc., also known as PetMeds, is an online pet pharmacy based in the United States. It is publicly traded and sells prescription and non-prescription pet medication.

Business model

PetMed Express is an online pharmacy that sells prescription and non-prescription pet medication and nutritional supplements. It can only fill prescriptions written by veterinarians, and competes with veterinarians who derive some of their income from selling pet medication.

History

Petmed Express was founded in Florida in 1996 by Marc Puleo. Puleo was an anesthesiologist who wanted to open a mail-order business for human prescriptions that also sold pet accessories. He shifted his focus to pet medicines due to Merck already heavily controlling the human prescription market. The company initially grew through word of mouth, television commercials, and its catalogs.

Its stock was traded on the OTC Bulletin Board under the symbol PETS from September 1997 until March 2000; in March 2000 the company began the process of becoming listed on the National Quotation Bureau Electronic Quotation Service and became responsible for reporting to the SEC.

Until 2002 PetMed Express and a company called Savemax Inc. operated in the same premises, shared staff, and operated under the same pharmacy licenses. According to the lawyer for both companies, Savemax was formed because of "a concern over PetMed's liability, and whether it [would] continue." From 1999 to 2002, PetMed Express and SaveMax were charged with violating the pharmaceutical law in several states. In one instance it was fined by the Environmental Protection Agency for selling drugs in metric doses, and has also received a warning letter from the FDA for selling misbranded drugs. In 1999, PetMed Express settled charges with the Florida Pharmacy Board for selling drugs that did not have prescriptions, false advertising, poor record keeping, and not labelling drugs correctly.

In addition to pet medications, PetMed Express also sold pet accessories such as leashes. In 2000, Tricon Holdings invested $2 million into the company. The company also hired Menderes Akdag as CEO in 2001. It discontinued 5,000 products and began focusing strictly on medicine-related items.

In 2002, PetMed Express and Savemax were fined by the EPA for selling prescription drugs illegally. The drugs were made by Novartis for sale in Europe and Australia and the doses and labelling were not FDA-approved. Also in 2002, PetMed Express, this time with Savemax, the company reached a settlement with the Florida Pharmacy Board for contracting with veterinarians to write prescriptions for animals they had never examined. The Florida board provided information to national boards and encouraged other state boards to take actions against veterinarians who had worked with PetMed Express to provide prescriptions for animals they had not examined. In the same year, the company settled similar charges in Ohio. In November 2002, the pharmacy board in Texas filed a lawsuit charging PetMed Express with dispensing veterinary drugs without prescriptions. The case was settled in 2006 with a $50,000 fine and three years' probation.

In 2004 a securities class action lawsuit was filed against the company, claiming that the company was not candid about the difficulty in getting prescriptions authorized by veterinarians. In 2005, the lawsuits were voluntarily dismissed by the plaintiffs. Puleo stepped down from executive leadership with the company the same year. Another shareholder lawsuit was filed against the company in 2018, claiming that it marketed dangerous animal drugs to humans. The lawsuit was later dismissed by plaintiffs after investigation of the claims.

As announced by PetMed Express Inc. in a regulatory filing published on Friday, June 4, 2021, Menderes Akdag, chief executive officer, leaves the online pet pharmacy after around 20 years in the role. PetMed said: “On May 28, 2021, the Board of Directors of PetMed Express, Inc. (the “Company”) notified Menderes Akdag, President and Chief Executive Officer, that the Company will not extend Mr. Akdag’s employment agreement with the Company and that the employment agreement would therefore end on July 30, 2021 in accordance with the scheduled end date of the agreement. The Company has presented a proposal to Mr. Akdag regarding the continuation of his role as President and Chief Executive Officer for a transition period following July 30, 2021 until a new CEO is appointed.” Matthew N. Hulett, the former president of language learning giant Rosetta Stone, was named CEO and president effective August 30, 2021. Hulett entered into a three-year employment agreement with PetMed Express at a $500,000 base salary per year. He also received 90,000 shares of restricted stock and 510,000 shares of performance restricted stock.

In April 2022, the company signed a partnership with Vetster, a telehealth veterinary company. As part of the agreement, PetMeds will be the exclusive eCommerce provider of Vetster medications, and Vetster will be the exclusive provider of telehealth services to PetMeds customers.

In 2023, PetMed partnered with Pumpkin Pet Insurance a pet insurance provider. In 2025, PetMed launched PetHealthMD a pet care insurance provider.

Recognition

The company was picked 4th among Forbes magazine's 200 Best Small Business Companies in 2006 and number 6 in 2007. BusinessWeek named PetMed Express number 27 of its top 100 "Hot Growth Companies" in 2006.

== References ==

Sumber: Wikipedia (English), CC BY-SA 4.0 · Lihat di Wikipedia ↗

Wikidata ↗

sektorRetail industriRetail karyawan189 negaraUS

Kinerja 10 Tahun Tren Pendapatan, laba bersih, margin, dan EPS

06
Pendapatan$179M
2018-03-31 → 2026-03-31
EPS$-2.74
2018-03-31 → 2026-03-31
Arus Kas Bebas$-33M
2018-03-31 → 2026-03-31
Margin bersih-17.3%
2018-03-31 → 2026-03-31
Valuasi & Rasio 07–12

Valuasi Rasio P/E, P/S, P/B, EV/EBITDA — apakah sahamnya mahal atau murah?

Metrik Tren 5 Tahun PETS rata-rata 5T Median Rekan Kesimpulan
P/E (TTM) -1.0rata-rata 5T ≈9.3 ≈9.3 · ·
P/S (TTM) 0.2rata-rata 5T ≈0.3 ≈0.3 0.2 Nilai wajar
P/B (MRQ) 1.3rata-rata 5T ≈1.2 ≈1.2 · ·
Harga / FCF (TTM) -1.1rata-rata 5T ≈-247.6 ≈-247.6 · ·
Harga / Arus Kas (TTM) -1.2rata-rata 5T ≈13.4 ≈13.4 · ·
Harga / Nilai Buku Berwujud (MRQ) 1.7rata-rata 5T ≈2.2 ≈2.2 · ·

Median rekan dihitung berdasarkan basis standar per metrik dan mungkin tidak selalu cocok dengan basis TTM/MRQ yang ditampilkan untuk saham ini.

nilai · ≈ rata-rata 5T · median industri · penilaian relatif terhadap median

Dividen Yield, rasio pembayaran, riwayat dividen, CAGR 5 tahun

13
Imbal Hasil Dividen0.07%
Rasio Pembayaran Dividen-0.04%
Pembayaran Tahunan≈$1.20Dibayar triwulanan
Tanggal ex-dividenJumlahMata UangImbal Hasil
Agu 11, 2023$0,30USD≈9.4%
Jun 5, 2023$0,30USD≈8.2%
Feb 16, 2023$0,30USD≈6.1%
Nov 17, 2022$0,30USD≈6.3%
Agu 11, 2022$0,30USD≈5.4%
Mei 19, 2022$0,30USD≈5.9%
Feb 4, 2022$0,30USD≈5.0%
Nov 5, 2021$0,30USD≈3.8%
Agu 5, 2021$0,30USD≈4.0%
Mei 13, 2021$0,30USD≈4.1%
Jan 29, 2021$0,28USD≈2.9%
Nov 6, 2020$0,28USD≈3.7%
Jul 30, 2020$0,28USD≈3.5%
Mei 14, 2020$0,28USD≈3.4%
Jan 31, 2020$0,27USD≈4.3%
Nov 1, 2019$0,27USD≈4.7%
Agu 1, 2019$0,27USD≈6.7%
Mei 16, 2019$0,27USD≈5.5%
Feb 1, 2019$0,27USD≈4.6%
Nov 2, 2018$0,27USD≈3.7%

Riwayat Pendapatan EPS aktual vs perkiraan, kejutan %, tingkat keberhasilan, tanggal pendapatan berikutnya

14
Tingkat Kemenangan 0.00%
Kejutan Rata-rata -674.5%
Laporan Berikutnya Nov 11, 2026
PeriodeLaporanEPS AktualEPS EstimasiKejutan
31 Maret 2027 Agu 13, 2026 $-0.28 $0.12 -328.8%
31 Des. 2026 Jun 2, 2026 $-0.19 $-0.18 -3.5%
30 Juni 2026 Agu 13, 2026 $-0.28 $0.12 -328.8%
31 Maret 2026 $-0.19 $-0.18 -3.5%
31 Des. 2025 $-0.50 $-0.06 -717.0%
30 Juni 2025 $-1.65 $-0.07 -2210.9%
31 Maret 2025 $-0.56 $-0.05 -1129.2%
31 Des. 2024 $-0.03 $-0.01 —

Fundamental Lengkap Semua metrik per tahun — laporan laba rugi, neraca, arus kas

15
Laporan Laba Rugi 16
Metrik Tren 202620252024202320222021202020192018201720162015
Revenue $179M$227M$274M$248M$272M$304M$284M$283M$274M$249M$235M·
Cost of Revenue ·$158M$189M$171M$195M$219M$203M$188M$176M$170M$158M·
Gross Profit $50M$69M$85M$77M$77M$84M$81M$95M$98M$79M$76M·
SG&A Expense $51M$39M$55M$42M$31M$30M$25M$25M$24M$23M$21M·
Operating Expenses $109M$71M$93M$70M$53M$54M$50M$49M$46M$42M$44M·
Operating Income $-59M$-2M$-8M$6M$24M$31M$31M$46M$52M$37M$32M·
Interest Income ···$2M$335.0K$314.0K$2M$2M$658.0K$141.0K$190.0K·
Other Non-op $803.0K$758.0K$1M$944.0K$1M$1M$1M$1M$995.0K$300.0K$63.0K·
Pretax Income $-57M$-587.0K$-6M$7M$24M$31M$34M$49M$54M$38M$33M·
Income Tax $-73.0K$6M$1M$2M$5M$7M$8M$11M$17M$14M$12M·
Net Income $-57M$-6M$-7M$5M$19M$24M$26M$38M$37M$24M$21M·
EPS (Basic) $-2.74$-0.30$-0.37$0.25$0.93$1.19$1.29$1.84$1.83$1.18$1.02·
EPS (Diluted) $-2.74$-0.30$-0.37$0.25$0.92$1.19$1.29$1.84$1.82$1.17$1.02·
Shares (Basic) 20,921,36120,596,02220,395,95920,274,78620,175,93020,060,00020,041,00020,461,00020,346,00020,232,00020,124,000·
Shares (Diluted) 20,921,36120,596,02220,395,95920,339,00220,357,82020,119,00020,055,00020,491,00020,433,00020,378,00020,254,000·
EBITDA $-49M$6M$-1M$6M$26M$38M$31M$46M$52M···
Neraca 23
Metrik Tren 202620252024202320222021202020192018201720162015
Cash & Equivalents $21M$55M$55M$104M$111M$119M$104M$101M$78M$59M$38M$36M
Receivables $2M$2M$3M$2M$2M$3M$4M$3M$2M$2M··
Inventory $14M$16M$29M·········
Prepaid Expense $6M$5M$6M$5M$5M$5M$4M$1M$882.0K$1M··
Current Assets $44M$79M$94M$130M$151M$161M$129M$126M$105M$82M··
PP&E (Net) $26M$29M$27M$26M$24M$25M$25M$27M$29M$30M··
PP&E (Gross) $58M$54M$47M$41M$36M$36M$36M$36M$35M$34M··
Accum. Depreciation $32M$25M$20M$15M$12M$10M$11M$8M$6M$4M··
Goodwill $0$27M$27M$0········
Intangibles $5M$8M$11M$860.0K$860.0K$860.0K$860.0K$860.0K$860.0K$860.0K··
Total Assets $81M$149M$170M$167M$180M$187M$155M$154M$135M$113M··
Accounts Payable $21M$24M$37M$25M$28M$40M$20M$16M$15M$15M··
Current Liabilities $52M$63M$72M$58M$56M$45M$24M$19M$18M$18M··
Capital Leases $42.0K$535.0K$995.0K$0········
Deferred Tax $175.0K$263.0K$0$3M$0$1M$970.0K$1M····
Other Non-current Liabilities ···$0$0·······
Total Liabilities $52M$64M$73M$58M$56M$46M$25M$20M$19M$19M··
Common Stock $21.0K$21.0K$21.0K$21.0K$21.0K$20.0K$20.0K$21.0K$21.0K$21.0K··
Paid-in Capital $20M$19M$25M$18M$12M$7M$4M$12M$9M$7M··
Retained Earnings $9M$67M$72M$92M$112M$134M$126M$122M$106M$87M··
Stockholders' Equity $29M$85M$97M$110M$123M$125M$120M$135M$116M$93M$83M$75M
Liabilities + Equity $81M$149M$170M$167M$180M$187M$155M$154M$135M$113M··
Shares Outstanding 21,385,63820,657,00021,148,00021,084,00020,979,00020,269,00020,166,00020,674,00020,601,00020,526,000··
Arus Kas 15
Metrik Tren 202620252024202320222021202020192018201720162015
D&A $9M$7M$7M$4M$3M·······
Stock-based Comp $1M$-7M$7M$7M$5M$3M$3M$3M$3M$2M$2M·
Deferred Tax $-88.0K$5M$292.0K$-2M$-846.0K$-1M$-151.0K$125.0K$-92.0K$2M$-23.0K·
Amort. of Intangibles $2M$2M$2M$0········
Other Non-cash $18M$5M$-2M·········
Operating Cash Flow $-28M$5M$4M$28M$18M$40M$39M$45M$37M$47M$21M·
CapEx $5M$5M$5M$5M$2M$2M$2M$620.0K$703.0K$11M$20M·
Investing Cash Flow $-5M$-5M$-41M$-10M$-2M$-2M$-2M$-620.0K$-703.0K$-11M$-4M·
Stock Repurchased ····$0$0$11M$0····
Net Stock Activity ····$0$0$-11M·····
Dividends Paid $21.0K$181.0K$12M$25M$24M$23M$22M$22M$17M$16M$15M·
Financing Cash Flow $-299.0K$-181.0K$-12M$-25M$-24M$-23M$-33M$-22M$-17M$-16M$-15M·
Net Change in Cash $-33M$-576.0K$-49M$-7M$-8M$15M$3M$23M$19M$21M$2M·
Taxes Paid $52.0K$525.0K$130.0K$4M$6M$10M······
Free Cash Flow $-33M$-395.0K$-194.0K$23M$17M$38M$37M$45M$37M···
Profitabilitas 8
Metrik Tren 202620252024202320222021202020192018201720162015
Gross Margin 28.1%30.5%28.0%27.6%28.6%29.1%··35.7%···
Operating Margin -32.8%-0.67%-2.9%2.4%9.4%12.2%··19.0%···
Net Margin -32.0%-2.8%-2.7%2.0%7.7%9.9%··13.6%···
Pretax Margin -32.0%-0.26%-2.2%2.9%9.9%12.7%··19.7%···
EBITDA Margin -27.5%2.4%-0.39%2.4%9.4%12.2%··19.0%···
ROA -49.8%-3.9%-4.4%·11.6%17.8%16.7%26.1%30.1%···
ROE -100.4%-6.9%-7.2%·15.8%23.4%19.5%30.1%35.7%···
ROIC -202.5%-19.2%-10.0%·14.1%20.8%18.2%26.3%31.2%···
Likuiditas & Solvabilitas 2
Metrik Tren 202620252024202320222021202020192018201720162015
Current Ratio 0.81.31.3·4.53.65.36.85.8···
Quick Ratio 0.40.90.8·3.42.74.45.54.4···
Efisiensi 3
Metrik Tren 202620252024202320222021202020192018201720162015
Asset Turnover 1.61.41.7·1.51.8··2.2···
Inventory Turnover ·7.1··········
Receivables Turnover 84.781.1111.9·121.596.2··133.6···
Per Saham 6
Metrik Tren 202620252024202320222021202020192018201720162015
Book Value / Share $1.35$4.12$4.57·$6.78$6.97$6.45$6.51$5.62···
Revenue / Share $8.56$11.02$13.78$12.62$13.43$15.37··$13.40···
Cash Flow / Share $-1.36$0.23$0.21$1.37$0.91$1.99$1.94$2.20$1.83···
Cash / Share $1.00$2.65$2.61·$5.29$5.86$5.15$4.86$3.78···
Dividend / Share $0.00$0.00$0.60$1.20$1.20$1.12$1.08$1.06$0.85$0.76$0.72·
EPS (TTM) $-2.74$-0.30$-0.37$0.25$0.92$1.19$1.29$1.84$1.82$1.17$1.02$0.80
Tingkat Pertumbuhan 6
Metrik Tren 202620252024202320222021202020192018201720162015
Revenue YoY -21.1%-17.2%10.7%-9.1%-10.3%·······
Revenue CAGR 3Y -10.2%-5.9%-3.4%·········
Revenue CAGR 5Y -10.0%···········
EPS YoY ···-72.8%-22.7%·······
Net Income YoY ···-72.5%-21.8%·······
Dividends Paid CAGR 5Y -75.3%···········
Valuasi (TTM) 13
Metrik Tren 202620252024202320222021202020192018201720162015
Revenue TTM $179M$227M$274M$248M$272M$304M$284M$283M$274M$249M$235M$227M
Net Income TTM $-57M$-6M$-7M$5M$19M$24M$26M$38M$37M$24M$21M$17M
Market Cap $49M$87M$101M·$541M$713M$580M$471M$860M···
P/E -0.8-14.0-12.965.028.029.622.312.422.917.217.620.6
P/S 0.30.40.4·2.02.32.01.73.1···
P/B 1.71.01.0·3.85.04.53.57.4···
P / Tangible Book 2.11.71.73.14.45.7······
P / Cash Flow -1.718.323.5·29.317.814.910.423.0···
P / FCF -1.5-219.1-522.2·32.318.915.910.623.5···
Dividend Yield 0.04%0.21%12.3%·4.5%3.2%3.8%4.7%2.0%···
Earnings Yield -120.2%-7.2%-7.7%1.5%3.6%3.4%4.5%8.1%4.4%5.8%5.7%4.8%
Payout Ratio -0.04%-2.9%-166.6%477.4%115.6%74.1%84.3%58.1%46.9%···
Annual Payout $21.0K$181.0K$12M$25M$24M$23M$22M$22M$17M$16M$15M·

Periode terbaru di sebelah kiri · nilai null ditampilkan sebagai ·

Laporan Keuangan Laporan laba rugi, neraca, arus kas — tahunan, 5 tahun terakhir

16
Metrik 2026-03-312025-03-312024-03-312023-03-312022-12-31
Pendapatan $179M $227M $274M $248M ·
Margin Kotor % 28.1% 30.5% 28.0% 27.6% ·
Margin Operasi % -32.8% -0.67% -2.9% 2.4% ·
Laba Bersih $-57M $-6M $-7M $5M ·
EPS Dilusian $-2.74 $-0.30 $-0.37 $0.25 ·

Pemilik institusional (13F) 53 pengaju · $11.9M total · Per tanggal 30 Juni 2026

17

Institusi yang melaporkan kepemilikan saham ini dalam SEC Form 13F triwulanan mereka. Hanya posisi panjang; satu pengaju dapat muncul dua kali untuk leg opsi terpisah. Kaki put/call offset yang besar biasanya mencerminkan pembuatan pasar atau inventaris yang dilindungi, bukan keyakinan arah.

Pemegang 53
Nilai yang dipegang $11.9M
Posisi baru 10
Posisi yang keluar 8
Aktivitas institusional — Q2 2026 vs kuartal sebelumnya
Posisi baru Posisi yang keluar Meningkat Menurun Perubahan bersih saham
10 (0 vs Kuartal sebelumnya) 8 (-2 vs Kuartal sebelumnya) 9 (-1 vs Kuartal sebelumnya) 18 (+2 vs Kuartal sebelumnya) -1.3M

Dibandingkan dengan Q1 2026. Pengajuan Formulir 13F SEC jatuh tempo dalam waktu 45 hari setelah akhir kuartal ditambah kelonggaran singkat untuk pengaju terlambat — kuartal yang masih dalam jangka waktu tersebut dilewati demi pasangan terakhir yang dilaporkan sepenuhnya.

Institusi Nilai Saham % dari 13F yang dilacak Tipe
VANGUARD GROUP INC $3.084.028 963.759 26,00% Saham
RENAISSANCE TECHNOLOGIES LLC $2.171.962 1.131.230 18,31% Saham
VANGUARD CAPITAL MANAGEMENT LLC $1.588.602 827.397 13,39% Saham
BlackRock, Inc. $1.091.050 568.255 9,20% Saham
FEDERATED HERMES, INC. $407.367 212.170 3,43% Saham
GEODE CAPITAL MANAGEMENT, LLC $391.947 204.075 3,30% Saham
STEEL PARTNERS HOLDINGS L.P. $371.835 193.664 3,13% Saham
UBS Group AG $265.594 138.330 2,24% Saham
BRIDGEWAY CAPITAL MANAGEMENT, LLC $232.412 121.048 1,96% Saham
Rangeley Capital, LLC $232.320 121.000 1,96% Saham
VANGUARD FIDUCIARY TRUST CO $212.124 110.481 1,79% Saham
STATE STREET CORP $201.932 105.173 1,70% Saham
Formidable Asset Management, LLC $195.056 85.551 1,64% Saham
Empowered Funds, LLC $158.108 82.348 1,33% Saham
TUDOR INVESTMENT CORP ET AL $156.301 81.407 1,32% Saham
ARROWSTREET CAPITAL, LIMITED PARTNERSHIP $152.646 79.503 1,29% Saham
CITADEL ADVISORS LLC $142.324 74.127 1,20% Saham
DIMENSIONAL FUND ADVISORS LP $115.811 60.353 0,98% Saham
UMB Bank, n.a. $115.200 60.000 0,97% Saham
SUSQUEHANNA INTERNATIONAL GROUP, LLP $91.647 47.733 0,77% Saham
NORTHERN TRUST CORP $81.893 42.653 0,69% Saham
XTX Topco Ltd $80.511 41.933 0,68% Saham
CIBC Private Wealth Group LLC $75.300 30.000 0,63% Saham
SIMPLEX TRADING, LLC $47.702 24.845 0,40% Saham
IMC-Chicago, LLC $44.014 22.924 0,37% Saham
TUDOR INVESTMENT CORP ET AL $29.568 15.400 0,25% Opsi beli
Jain Global LLC $26.148 13.619 0,22% Saham
AMERICAN CENTURY COMPANIES INC $24.712 12.871 0,21% Saham
MORGAN STANLEY $22.282 11.604 0,19% Saham
BNP PARIBAS FINANCIAL MARKETS $17.637 9.186 0,15% Saham
Vanguard Global Advisers, LLC $15.590 8.120 0,13% Saham
OSAIC HOLDINGS, INC. $6.772 3.527 0,06% Saham
SBI Securities Co., Ltd. $2.148 1.119 0,02% Saham
Bank & Trust Co $2.054 901 0,02% Saham
HARBOUR INVESTMENTS, INC. $1.037 540 0,01% Saham
Accredited Wealth Management, LLC $1.004 5.636 0,01% Saham
Allworth Financial LP $949 494 0,01% Saham
MCF Advisors LLC $768 400 0,01% Saham
JONES FINANCIAL COMPANIES LLLP $730 415 0,01% Saham
Ascentis Independent Advisors $683 356 0,01% Saham
WELLS FARGO & COMPANY/MN $577 300 0,00% Saham
ROTHSCHILD INVESTMENT LLC $480 250 0,00% Saham
Tower Research Capital LLC (TRC) $323 168 0,00% Saham
Farther Finance Advisors, LLC $290 151 0,00% Saham
PRICE T ROWE ASSOCIATES INC /MD/ $250 129.933 0,00% Saham
FMR LLC $115 60 0,00% Saham
Elevated Capital Advisors, LLC $96 50 0,00% Saham
Caitong International Asset Management Co., Ltd $23 12 0,00% Saham
CITIGROUP INC $17 9 0,00% Saham
CoreCap Advisors, LLC $8 4 0,00% Saham

Tampilkan semua 53 pemilik institusional →

Aktivis & pemilik 5%+ 2 saham

18

Investor yang mengajukan Jadwal 13D SEC — kepemilikan manfaat di atas 5% dengan niat untuk memengaruhi penerbit (kepemilikan aktivis, kampanye dewan, M&A). Setiap baris menunjukkan status terbaru yang diketahui dari posisi pengaju tersebut.

Pengaju Diajukan Kepemilikan Status Tujuan Pengajuan
SilverCape Investments Limited, Peter Kennedy ×3 pengajuan 29 Juni 2026 12,07% Amandemen Investasi pasif SEC
Diveroli Investment Group LLC, Kingbird Ventures LLC 11 Feb. 2026 1,83% Pengajuan awal · SEC

Purpose is an automated classification of the filer's own stated purpose (SEC Item 4) — not investment advice. "—" means no clear purpose was stated or the text could not be classified.

Orang dalam perusahaan 29 orang dalam · 8 pejabat · 16 direktur

19
Orang Dalam Peran Aktivitas terakhir Saham dimiliki Beli 12m Jual 12m Bersih 12m
Jeffrey Allen Willard CEO and President 28 Sep. 2026 A 250.000 0 0 $0
Leslie C.G. Campbell Interim CEO and President 11 Agu 2026 A 145.000 0 0 $0
Sandra Yvette Campos CEO & President 30 April 2025 S 578.524 0 0 $0
Menderes Akdag CEO & President 27 Jan. 2021 S 337.800 0 0 $0
Douglas Krulik CAO and Interim CFO 26 Juni 2026 A 102.500 0 0 $0
Robyn M. D'Elia Chief Financial Officer 27 Sep. 2024 A 250.000 0 0 $0
Christine Chambers CFO 31 Mei 2024 D 65.146 0 0 $0
Bruce S Rosenbloom Chief Financial Officer 30 Juli 2021 A 45.450 0 0 $0
Tamar Elkeles Direktur 17 Sep. 2026 A 49.923 0 0 $0
Peter Batushansky Direktur 11 Agu 2026 A 91.928 0 0 $0
Justin L. Mennen Direktur 11 Agu 2026 A 98.274 0 0 $0
Gian Fulgoni Direktur 21 Jan. 2026 D 132.299 0 0 $0
Leah Solivan Direktur 30 Okt. 2025 A 42.289 0 0 $0
Diana G Purcel Direktur 8 Agu 2024 A 24.375 0 0 $0
Jodi Watson Direktur 28 Juli 2022 A 18.880 0 0 $0
Peter Cobb Direktur 28 Juli 2022 A 15.000 0 0 $0
Ronald J Korn Direktur 30 Juli 2021 A 90.833 0 0 $0
Frank J Formica Direktur 29 Jan. 2021 S 55.000 0 0 $0
Robert C Schweitzer Direktur 28 Agu 2020 S 95.834 0 0 $0
Marc Puleo MD Direktur 16 Agu 2005 J 913.286 0 0 $0
SilverCape Investments Limited Pemilik 10% 13 Agu 2025 P 2.579.696 0 0 $0
TRICON HOLDINGS LLC Pemilik 10% 4 Agu 2006 S 2.284.000 0 0 $0
James Lacamp · 11 Agu 2026 A 90.421 0 0 $0
Jacqueline Paula Smith · 15 Jan. 2025 A 28.099 0 0 $0
Mathew N Hulett · 29 April 2024 D 103.850 0 0 $0
Mark Bradley Moseley JR · 11 Des. 2023 A 42.000 0 0 $0
Daniel Job Pingree · 17 Mei 2023 A 22.000 0 0 $0
CRESLIN LTD · 4 Agu 2006 S 2.284.000 0 0 $0
Guven Kivilcim · 22 Jan. 2004 S 1.310.300 0 0 $0

Orang dalam dari pengajuan SEC Form 3/4/5; bersih = hanya P/S pasar terbuka

Kepemilikan ETF Dimiliki oleh 20 ETF

20

Bobot mencerminkan kepemilikan ekuitas langsung (N-PORT) saja; dana berbasis leverage atau derivatif mungkin memiliki eksposur swap tambahan yang tidak ditampilkan.

Dana Bobot Unit Per tanggal Sumber
EWUS · iShares Trust 0,25% 37.222 SH 11 Sep. 2026 Harian
ISVL · iShares Trust 0,17% 202.554 SH 11 Sep. 2026 Harian
ISCF · iShares Trust 0,09% 216.018 SH 11 Sep. 2026 Harian
IEUS · iShares Trust 0,07% 45.419 SH 11 Sep. 2026 Harian
PDN · Invesco Exchange-Traded Fund Trust … 0,05% 58.613 SH 2 Okt. 2026 Harian
SCZ · iShares Trust 0,03% 1.496.647 SH 11 Sep. 2026 Harian
VSS · VANGUARD INTERNATIONAL EQUITY INDEX… 0,03% 1.566.925 SH 19 Agu 2026 Harian
WSML · iShares Trust 0,01% 26.193 SH 11 Sep. 2026 Harian
VGK · VANGUARD INTERNATIONAL EQUITY INDEX… 0,01% 1.056.528 SH 19 Agu 2026 Harian
IEUR · iShares Trust 0,01% 291.699 SH 11 Sep. 2026 Harian
IWC · iShares Trust 0,01% 51.213 SH 11 Sep. 2026 Harian
IEFA · iShares Trust 0,00% 3.372.753 SH 11 Sep. 2026 Harian
IDEV · iShares Trust 0,00% 546.389 SH 11 Sep. 2026 Harian
IXUS · iShares Trust 0,00% 684.652 SH 11 Sep. 2026 Harian
VXF · VANGUARD INDEX FUNDS 0,00% 211.088 SH 19 Agu 2026 Harian
VTI · VANGUARD INDEX FUNDS 0,00% 602.795 SH 19 Agu 2026 Harian
VXUS · VANGUARD STAR FUNDS 0,00% 6.557.275 SH 19 Agu 2026 Harian
VT · VANGUARD INTERNATIONAL EQUITY INDEX… 0,00% 341.189 SH 19 Agu 2026 Harian
VEA · VANGUARD TAX-MANAGED FUNDS 0,00% 4.366.658 SH 19 Agu 2026 Harian
VSGX · VANGUARD WORLD FUND 0,00% 78.854 SH 19 Agu 2026 Harian

PETS Konsensus Analis Opini analis bullish dan bearish, target harga 12 bulan, potensi kenaikan

21
peringkat · 6 analis JUAL
Target median $1.40 +2,9%
0 0,0% Beli Kuat
0 0,0% Beli
2 33,3% Tahan
2 33,3% Jual
2 33,3% Jual Kuat

Target Harga 12 Bulan

1 analis · 2026-10-01

Target rata-rata $1.40 +2,9%

Rendah$1.40 Rata-rata$1.40 Tinggi$1.40

Perbandingan rekan (sub-industri GICS) Metrik utama vs rekan sektor

22

Dasar FY, harga per penutupan akhir tahun fiskal terakhir setiap perusahaan.

Ticker Kapitalisasi Pasar P/E Pendapatan YoY Margin Bersih ROE Margin Kotor
PETS $49M -0.8 -21.1% -32.0% -100.4% 28.1%
RENT · 3.7 7.7% 6.9% -16.9% ·
GROV $46M -3.2 -14.6% -6.7% 75.6% 53.7%
SPWH $52M -1.1 0.96% -4.1% -25.2% 30.9%
LESL $46M -0.2 -6.6% -19.1% 70.0% 35.4%
ULTA $27.83B 24.6 9.7% 9.3% 42.7% 39.1%

Metrik Saya Daftar pantauan pribadi Anda — baris yang dipilih dari Fundamental Lengkap

26

Pilih metrik yang penting bagi Anda — klik + di sebelah baris mana pun di Fundamental Lengkap di atas.

Pilihan Anda disimpan dan mengikuti Anda di semua ticker.

Sumber: SEC 10-Q diajukan Agu 13, 2026